As of 2025-11-01, the Relative Valuation of Fate Therapeutics Inc (FATE) is (21.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -1708.4%.
The range of the Relative Valuation is (21.00) - (22.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.1x | 14.6x |
| Forward P/E multiples | 14.1x - 15.1x | 14.6x |
| Fair Price | (21.00) - (22.43) | (21.71) |
| Upside | -1655.5% - -1761.3% | -1708.4% |
| Date | P/E |
| 2025-10-30 | -0.87 |
| 2025-10-29 | -0.90 |
| 2025-10-28 | -1.00 |
| 2025-10-27 | -1.04 |
| 2025-10-24 | -1.11 |
| 2025-10-23 | -1.02 |
| 2025-10-22 | -1.00 |
| 2025-10-21 | -1.03 |
| 2025-10-20 | -1.04 |
| 2025-10-17 | -0.99 |
| 2025-10-16 | -1.04 |
| 2025-10-15 | -1.03 |
| 2025-10-14 | -1.01 |
| 2025-10-13 | -0.93 |
| 2025-10-10 | -1.10 |
| 2025-10-09 | -1.08 |
| 2025-10-08 | -1.02 |
| 2025-10-07 | -0.93 |
| 2025-10-06 | -0.95 |
| 2025-10-03 | -0.81 |
| 2025-10-02 | -0.81 |
| 2025-10-01 | -0.84 |
| 2025-09-30 | -0.85 |
| 2025-09-29 | -0.67 |
| 2025-09-26 | -0.67 |
| 2025-09-25 | -0.65 |
| 2025-09-24 | -0.68 |
| 2025-09-23 | -0.65 |
| 2025-09-22 | -0.68 |
| 2025-09-19 | -0.65 |
| 2025-09-18 | -0.67 |
| 2025-09-17 | -0.64 |
| 2025-09-16 | -0.64 |
| 2025-09-15 | -0.64 |
| 2025-09-12 | -0.65 |
| 2025-09-11 | -0.69 |
| 2025-09-10 | -0.67 |
| 2025-09-09 | -0.66 |
| 2025-09-08 | -0.65 |
| 2025-09-05 | -0.68 |
| 2025-09-04 | -0.65 |
| 2025-09-03 | -0.67 |
| 2025-09-02 | -0.69 |
| 2025-08-29 | -0.70 |
| 2025-08-28 | -0.73 |
| 2025-08-27 | -0.75 |
| 2025-08-26 | -0.75 |
| 2025-08-25 | -0.73 |
| 2025-08-22 | -0.77 |
| 2025-08-21 | -0.75 |